RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rekah Pharmaceutical Industry Stock

Rekah Pharmaceutical Industry P/S 2024

Rekah Pharmaceutical Industry P/S

60.5

Ticker

REKA.TA

ISIN

IL0010810096

As of Dec 24, 2024, Rekah Pharmaceutical Industry's P/S ratio stood at 60.5, a -23.28% change from the 78.86 P/S ratio recorded in the previous year.

The Rekah Pharmaceutical Industry P/S history

Rekah Pharmaceutical Industry Aktienanalyse

What does Rekah Pharmaceutical Industry do?

Rekah Pharmaceutical Industry ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Rekah Pharmaceutical Industry's P/S Ratio

Rekah Pharmaceutical Industry's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Rekah Pharmaceutical Industry's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Rekah Pharmaceutical Industry's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Rekah Pharmaceutical Industry’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Rekah Pharmaceutical Industry stock

What is the price-to-earnings ratio of Rekah Pharmaceutical Industry?

The price-earnings ratio of Rekah Pharmaceutical Industry is currently 60.5.

How has the price-earnings ratio of Rekah Pharmaceutical Industry changed compared to last year?

The price-to-earnings ratio of Rekah Pharmaceutical Industry has increased by -23.28% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Rekah Pharmaceutical Industry high compared to other companies?

Yes, the price-to-earnings ratio of Rekah Pharmaceutical Industry is high compared to other companies.

How does an increase in the price-earnings ratio of Rekah Pharmaceutical Industry affect the company?

An increase in the price-earnings ratio of Rekah Pharmaceutical Industry would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Rekah Pharmaceutical Industry affect the company?

A decrease in the price-earnings ratio of Rekah Pharmaceutical Industry would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Rekah Pharmaceutical Industry?

Some factors that influence the price-earnings ratio of Rekah Pharmaceutical Industry are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Rekah Pharmaceutical Industry pay?

Over the past 12 months, Rekah Pharmaceutical Industry paid a dividend of 0.87 ILS . This corresponds to a dividend yield of about 0.07 %. For the coming 12 months, Rekah Pharmaceutical Industry is expected to pay a dividend of 0.87 ILS.

What is the dividend yield of Rekah Pharmaceutical Industry?

The current dividend yield of Rekah Pharmaceutical Industry is 0.07 %.

When does Rekah Pharmaceutical Industry pay dividends?

Rekah Pharmaceutical Industry pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rekah Pharmaceutical Industry?

Rekah Pharmaceutical Industry paid dividends every year for the past 0 years.

What is the dividend of Rekah Pharmaceutical Industry?

For the upcoming 12 months, dividends amounting to 0.87 ILS are expected. This corresponds to a dividend yield of 0.07 %.

In which sector is Rekah Pharmaceutical Industry located?

Rekah Pharmaceutical Industry is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rekah Pharmaceutical Industry kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rekah Pharmaceutical Industry from 4/14/2022 amounting to 0.868 ILS, you needed to have the stock in your portfolio before the ex-date on 4/6/2022.

When did Rekah Pharmaceutical Industry pay the last dividend?

The last dividend was paid out on 4/14/2022.

What was the dividend of Rekah Pharmaceutical Industry in the year 2023?

In the year 2023, Rekah Pharmaceutical Industry distributed 0 ILS as dividends.

In which currency does Rekah Pharmaceutical Industry pay out the dividend?

The dividends of Rekah Pharmaceutical Industry are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rekah Pharmaceutical Industry

Our stock analysis for Rekah Pharmaceutical Industry Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rekah Pharmaceutical Industry Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.